Biodegradable Nanoparticle-Entrapped Vaccine Induces Cross-Protective Immune Response against a Virulent Heterologous Respiratory Viral Infection in Pigs

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Dwivedi, Varun ^a,c   Manickam, Cordelia ^a,c   Binjawadagi, Basavaraj ^a,c   Joyappa, Dechamma ^b   Renukaradhya, Gourapura J ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; POLYGLACTIN; VIRUS ANTIGEN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTERIVIRUS; ARTICLE; CELL PHAGOCYTOSIS; CELL POPULATION; CONTROLLED STUDY; CROSS PROTECTION; CYTOKINE RELEASE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION PREVENTION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; UPREGULATION; VIREMIA; VIRUS LOAD; VIRUS VIRULENCE;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG DELIVERY SYSTEMS; LUNG; NANOPARTICLES; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RESPIRATORY TRACT INFECTIONS; SUS SCROFA; SWINE; VIRAL VACCINES;

ANIMALIA; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

EID: 84871117280     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051794     Document Type: Article

References (50)

1. Aguado MT, Lambert PH, (1992) Controlled-release vaccines-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology 184: 113-125.
2. Park TG, (1994) Degradation of poly(D,L-lactic acid) microspheres effect of molecular weight. J Control Release 30: 161-173.
3. Hein WR, Griebel PJ, (2003) A road less travelled: large animal models in immunological research. Nat Rev Immunol 3: 79-84.
4. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, et al. (2008) The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 295: L240-263.
5. Holtkamp D, Kliebenstein J (2011) PRRS Costs Industry $664 Million Annually. Pork Checkoff Study, http://wwwporkorg/News/1265/PRRSCostsIndustry664Millionaspx.
6. Cavanagh D, (1997) Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142: 629-633.
7. Done SH, Paton DJ, (1995) Porcine reproductive and respiratory syndrome: clinical disease, pathology and immunosuppression. Vet Rec 136: 32-35.
8. Halbur PG, Miller LD, Paul PS, Meng XJ, Huffman EL, et al. (1995) Immunohistochemical identification of porcine reproductive and respiratory syndrome virus (PRRSV) antigen in the heart and lymphoid system of three-week-old colostrum-deprived pigs. Vet Pathol 32: 200-204.
9. Dwivedi V, Manickam C, Binjawadagi B, Linhares D, Murtaugh MP, et al. (2012) Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions. Virol J 9: 45.
10. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM, (1992) Mucosal immunity: implications for vaccine development. Immunobiology 184: 157-179.
11. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75-88.
12. Mestecky J, Michalek SM, Moldoveanu Z, Russell MW (1997) Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst Mitt: 33-43.
13. Thomas C, Rawat A, Hope-Weeks L, Ahsan F, (2011) Aerosolized PLA and PLGA Nanoparticles Enhance Humoral, Mucosal and Cytokine Responses to Hepatitis B Vaccine. Mol Pharm 8: 405-415.
14. Singh M, Briones M, O'Hagan DT, (2001) A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J Control Release 70: 267-276.
15. Baras B, Benoit MA, Dupre L, Poulain-Godefroy O, Schacht AM, et al. (1999) Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen. Infect Immun 67: 2643-2648.
16. Mengeling WL, Lager KM, Vorwald AC, Koehler KJ, (2003) Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet Microbiol 93: 13-24.
17. Renukaradhya GJ, Dwivedi V, Manickama C, Binjawadagia B, Benfield D, (2012) Mucosal vaccines to prevent porcine reproductive and respiratory syndrome: a new perspective. Animal Health Research Review 13: 1-17 doi:10.1017/S1466252312000023.
18. Leroith T, Hammond S, Todd SM, Ni Y, Cecere T, et al. (2011) A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae. Vet Immunol Immunopathol 140: 312-316.
19. Li B, Fang L, Xu Z, Liu S, Gao J, et al. (2009) Recombination in vaccine and circulating strains of porcine reproductive and respiratory syndrome viruses. Emerg Infect Dis 15: 2032-2035.
20. Nielsen HS, Oleksiewicz MB, Forsberg R, Stadejek T, Botner A, et al. (2001) Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 82: 1263-1272.
21. Bassaganya-Riera J, Thacker BJ, Yu S, Strait E, Wannemuehler MJ, et al. (2004) Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells. Viral Immunol 17: 25-37.
22. Kim WI, Lee DS, Johnson W, Roof M, Cha SH, et al. (2007) Effect of genotypic and biotypic differences among PRRS viruses on the serologic assessment of pigs for virus infection. Vet Microbiol 123: 1-14.
23. Piotrowicz A (2005) Incorporation of microspheres into nerve guidance channels for drug delivery purposes. Applied Chemistry and Chemical Enginnering, University of Toronto, Toronto: p. 108.
24. Cao X, Schoichet MS, (1999) Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 20: 329-339.
25. Rajapaksa TE, Bennett KM, Hamer M, Lytle C, Rodgers VG, et al. (2010) Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength. J Biol Chem 285: 23739-23746.
26. Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, et al. (2010) Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol 84: 11210-11218.
27. Carrasco CP, Rigden RC, Schaffner R, Gerber H, Neuhaus V, et al. (2001) Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology 104: 175-184.
28. Jung K, Alekseev KP, Zhang X, Cheon DS, Vlasova AN, et al. (2007) Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. J Virol 81: 13681-13693.
29. Grumelli S, Corry DB, Song LZ, Song L, Green L, et al. (2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1: e8.
30. Christopher-Hennings J, Holler LD, Benfield DA, Nelson EA, (2001) Detection and duration of porcine reproductive and respiratory syndrome virus in semen, serum, peripheral blood mononuclear cells, and tissues from Yorkshire, Hampshire, and Landrace boars. J Vet Diagn Invest 13: 133-142.
31. Dwivedi V, Manickam C, Patterson R, Dodson K, Murtaugh M, et al. (2011) Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant. Vaccine 29: 4058-4066.
32. Greenway TE, Eldridge JH, Ludwig G, Staas JK, Smith JF, et al. (1998) Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Vaccine 16: 1314-1323.
33. Shephard MJ, Todd D, Adair BM, Po AL, Mackie DP, et al. (2003) Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice. Res Vet Sci 74: 187-190.
34. Albina E, Carrat C, Charley B, (1998) Interferon-alpha response to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. J Interferon Cytokine Res 18: 485-490.
35. Inaba K, Inaba M, Naito M, Steinman RM, (1993) Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178: 479-488.
36. Gupta RK, Chang AC, Siber GR, (1998) Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Dev Biol Stand 92: 63-78.
37. Yoshida M, Babensee JE, (2006) Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 79: 393-408.
38. Babensee JE, Paranjpe A, (2005) Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 74: 503-510.
39. Ganter M, Hensel A, (1997) Cellular variables in bronchoalveolar lavage fluids (BALF) in selected healthy pigs. Res Vet Sci 63: 215-217.
40. Schaumann F, Borm PJ, Herbrich A, Knoch J, Pitz M, et al. (2004) Metal-rich ambient particles (particulate matter 2.5) cause airway inflammation in healthy subjects. Am J Respir Crit Care Med 170: 898-903.
41. Aiba S, (1992) Studies on chitosan: 4. Lysozymic hydrolysis of partially N-acetylated chitosans. Int J Biol Macromol 14: 225-228.
42. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S, (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667.
43. Shibata Y, Foster LA, Metzger WJ, Myrvik QN, (1997) Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 65: 1734-1741.
44. Nagao G, Ishii K, Hirota K, Makino K, Terada H, (2011) Role of lipid rafts in innate immunity and phagocytosis of polystyrene latex microspheres. Colloids Surf B Biointerfaces 84: 317-324.
45. Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, et al. (2004) Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. J Med Virol 73: 368-377.
46. Olin MR, Batista L, Xiao Z, Dee SA, Murtaugh MP, et al. (2005) Gammadelta lymphocyte response to porcine reproductive and respiratory syndrome virus. Viral Immunol 18: 490-499.
47. Welsh RM, Lin MY, Lohman BL, Varga SM, Zarozinski CC, et al. (1997) Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections. Immunol Rev 159: 79-93.
48. Dwivedi V, Manickam C, Patterson R, Dodson K, Weeman M, et al. (2011) Intranasal delivery of whole cell lysate of Mycobacterium tuberculosis induces protective immune responses to a modified live porcine reproductive and respiratory syndrome virus vaccine in pigs. Vaccine 29: 4067-4076.
49. Ogra PL, Karzon DT, (1969) Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol 102: 1423-1430.
50. Liew FY, Russell SM, Appleyard G, Brand CM, Beale J, (1984) Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol 14: 350-356.